I am grateful for the developer of Herceptin and Perjeta for HER2+ breast cancer. I took both drugs (via my chemo port) every 3 weeks for 1 year. This treatment has an amazing success rate for stopping reoccurrence in HER2+ breast cancer.
Quote
Manage Consent
We use technical and analytics cookies to ensure that we give you the best experience on our website.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
